Skip to content

Serotonin: all studies

Page 345 of 400: studies 3,441 to 3,450 of 3,999, newest first. Back to the serotonin overview

Research

Modulatory effects of low-dose MDMA on cocaine-induced locomotor activity and place conditioning in rats.

Pharmacology, Biochemistry, and Behavior January 2012 John J Panos, Lisa E Baker

Methylenedioxymethamphetamine (MDMA; "Ecstasy") is commonly abused by humans in environments such as nightclubs and rave parties where other drugs of abuse are readily available. Despite the popularity of polysubstance abuse among recreational MDMA users, relatively few controlled experimental studies have documented the neurobehavioral effects of MDMA in combination with other abused...

Dreaming and hallucinations - continuity or discontinuity? Perspectives from dementia with Lewy bodies.

Consciousness and Cognition December 2011 Daniel Collerton, Elaine K. Perry

Comparing the phenomenology, neurochemical pathology, and psychopharmacology of hallucinations and dreaming is limited by the available data. Evidence to date reveals no simple correspondence between the two states. Differences in the phenomenology of visual hallucinations and the visual component of dreams may reflect variations in visual context acting on the same underlying mechanism - the...

Modulation of human GABAA receptor function: a novel mode of action of drugs of abuse.

Neurotoxicology December 2011 Laura Hondebrink, Jan Meulenbelt, Regina G D M Van Kleef et al.

Drugs of abuse are known to mainly affect the dopaminergic and serotonergic system, although behavioral studies indicated that the GABA-ergic system also plays a role. We therefore investigated the acute effects of several commonly used drugs of abuse (methamphetamine, amphetamine, 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA) and meta-chlorophenylpiperazine...

Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats.

Neuropharmacology December 2011 Erica Y Shen, Syed F. Ali, Jerrold S. Meyer

Most recreational users of 3, 4-methylenedioxymethamphetamine (MDMA or "ecstasy") also take cannabis, in part because cannabis can reduce the dysphoric symptoms of the ecstasy come-down such as agitation and insomnia. Although previous animal studies have examined the acute effects of co-administering MDMA and Δ(9)-tetrahydrocannabinol (THC), which is the major psychoactive ingredient in...

Effects of lamotrigine on PCP-evoked elevations in monoamine levels in the medial prefrontal cortex of freely moving rats.

Journal of Psychopharmacology December 1, 2011 Davide Quarta, Charles H Large

Lamotrigine is suggested to have potential as an add-on treatment for patients with schizophrenia. Supporting evidence comes from the efficacy of the drug in models of psychotic-like behaviour induced by N-methyl-D-aspartate (NMDA) receptor antagonists, such as phencyclidine (PCP). These drugs enhance levels of the monoamines in the cortex, which may contribute to their psychotomimetic effects....

Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.

Psychopharmacology November 2011 Charlotte Klein, Emily Karanges, Adena Spiro et al.

The interactions between Δ(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD) during chronic treatment, and at equivalent doses, are not well characterised in animal models. The aim of this study is to examine whether the behavioural effects of THC, and blood and brain THC levels are affected by pre-treatment with equivalent CBD doses. Adolescent rats were treated with ascending daily THC...

4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.

Journal of Pharmacology and Experimental Therapeutics November 2011 Gregory C Hadlock, Katy M Webb, Lisa M McFadden et al.

The designer stimulant 4-methylmethcathinone (mephedrone) is among the most popular of the derivatives of the naturally occurring psychostimulant cathinone. Mephedrone has been readily available for legal purchase both online and in some stores and has been promoted by aggressive Web-based marketing. Its abuse in many countries, including the United States, is a serious public health concern....

Salvia divinorum use and phenomenology: results from an online survey.

Journal of Psychopharmacology November 1, 2011 Harry Sumnall, Fiona Measham, Simon D. Brandt et al. 38 citations

Salvia divinorum is a hallucinogenic plant with ethnopharmacological and recreational uses. It differs from classic serotonergic hallucinogens such as LSD and psilocin in both phenomenology and potent agonist activity of the active component salvinorin A at κ-opioid receptors. Awareness of S. divinorum has grown recently, with both an increase in its public representation and concern over its...

DOI: 10.1177/0269881110385596 (opens in new tab) Full text (opens in new tab) Salvia divinorum Hallucinogenic plant Psychoactive plant User experiences +15

Antidepressant-like effects of 3,4-methylenedioxymethamphetamine in an animal model of depression

Behavioural Pharmacology October 6, 2011 Irina Majumder, Jason M. White, Rodney James Irvine 16 citations

Increased synaptic serotonin (5-hydroxytryptamine) levels may underlie antidepressant-like effects of 3,4-methylenedioxymethamphetamine (MDMA) that may be more prominent in subjects with mood disturbance. The Flinders Sensitive Line (FSL) strain is an important animal model of depression. These rats are more immobile in the forced swimming test (FST), and their immobility is reversed by known...

Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption

Journal of Psychopharmacology October 3, 2011 Kim Wolff, Eva-Maria Tsapakis, Carmine Maria Pariante et al. 37 citations

In this study we investigate the association of cytochrome P450 enzyme CYP2D6, catechol-O-methyl transferase (COMT, Val158Met) and serotonin transporter promoter (5-HTTLPR) genotypes on change in cortisol concentration following 3, 4-methylenedioxy-methamphetamine (MDMA, 'ecstasy') consumption. Forty-eight subjects (30 males, mean age 23 years), self-nominating regular clubbers provided 'in the...